Expert Opinion On Therapeutic Targets

Expert Opinion On Therapeutic Targets英文簡介

The journal evaluates molecules, signalling pathways, receptors and other therapeutic targets and their potential as candidates for drug development. Articles in this journal focus on the molecular level and early preclinical studies. Articles should not include clinical information including specific drugs and clinical trials.

The Editors welcome:

Reviews covering novel disease targets at the molecular level and information on early preclinical studies and their implications for future drug development.

Articles should not include clinical information including specific drugs and clinical trials.

Original research papers reporting results of target selection and validation studies and basic mechanism of action studies for investigative and marketed drugs.

The audience consists of scientists, managers and decision makers in the pharmaceutical industry, academic researchers working in the field of molecular medicine and others closely involved in R&D.

Expert Opinion On Therapeutic Targets中文簡介

《Expert Opinion On Therapeutic Targets》是一本由TAYLOR & FRANCIS LTD出版商出版的專業(yè)醫(yī)學(xué)期刊，該刊創(chuàng)刊于2001年，刊期Monthly，該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄。在中科院最新升級版分區(qū)表中，該刊分區(qū)信息為大類學(xué)科：醫(yī)學(xué) 2區(qū)，小類學(xué)科：藥學(xué) 2區(qū)；在JCR（Journal Citation Reports）分區(qū)等級為Q1。該刊發(fā)文范圍涵蓋藥學(xué)等領(lǐng)域，旨在及時、準(zhǔn)確、全面地報道國內(nèi)外藥學(xué)工作者在該領(lǐng)域取得的最新研究成果、工作進(jìn)展及學(xué)術(shù)動態(tài)、技術(shù)革新等，促進(jìn)學(xué)術(shù)交流，鼓勵學(xué)術(shù)創(chuàng)新。2021年影響因子為6.797，平均審稿速度偏慢,4-8周。

中科院分區(qū)最新升級版（當(dāng)前數(shù)據(jù)版本：2021年12月最新升級版）

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)	Top期刊	綜述期刊
醫(yī)學(xué)	2區(qū)	PHARMACOLOGY & PHARMACY 藥學(xué)	2區(qū)	否	是

JCR分區(qū)（當(dāng)前數(shù)據(jù)版本：2021-2022年最新版）

JCR分區(qū)等級	JCR所屬學(xué)科	分區(qū)	影響因子
Q1	PHARMACOLOGY & PHARMACY	Q1	6.797

期刊指數(shù)

影響因子	h-index	Gold OA文章占比	研究類文章占比	OA開放訪問	平均審稿速度
6.797	78	4.55%	22.86%	未開放	偏慢,4-8周

IF值(影響因子)趨勢圖